Related Experiment Video
Updated: Aug 17, 2026

Preparation of Enantiopure Non-Activated Aziridines and Synthesis of Biemamide B, D, and epiallo-Isomuscarine
Published on: June 13, 2022
[Alzoon--antineoplastic remedy or medicinal syrup?]
1Hämatologisches Zentrallabor, Inselspital/Universitätsspital, Bern.
Abstract:
Alzoon is a concoction containing extracts of petasites, juniper, ferns, brunellias, and dandelions that has been treated with oxygen and UV-light. A variety of indications are claimed: cachexia, severe pain, anemia as a result of malignant tumors, stomach or duodenal ulcers and also relief for desperate end-stage cancer patients. A long-term treatment is recommended. Prior to meals 2 to 3 times daily, 1-2 tablespoons of Alzoon are recommended. A bottle with 1 liter costs CHF 31.80. Apparently, Alzoon is harmless and free of side effects. Alzoon was patented in 1943 by the chemist M. R. von Niederhäusern from Basel. His company Alsana Inc. (pharmaceutical specialities, Thun, Switzerland) produces and sells Alzoon. A mechanism of action is not mentioned. Alzoon is sold as "holistic therapy", and is supposed to relieve pain, stimulate appetite, and enhance quality of life. The most important plant of the mixture is supposedly petasites. In the mid sixties a study on 42 patients was conducted under the pressure of the Alsana Inc. and v. Niederhäusern. The analysis of the results of the two experts showed that Alzoon had no influence on tumor growth. Six patients (14%) had a temporary improvement of quality of life and appetite. Further trials do not exist. In Switzerland, Alzoon is registered on the list D at the IKS, but is not reimbursable by insurance companies. It is not established as an anti-cancer remedy.
More Related Videos
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
08:44Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
Published on: May 19, 2026
Related Concept Videos
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Physical Properties of Amines
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pharmaceutical Poisoning: Treatment Strategies